Could SP-A and SP-D Serum Levels Predict COVID-19 Severity?
International Journal of Molecular Sciences · 22.05.2024 · 25 (11) · 5620
DOI: 10.3390/ijms25115620 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.05.2024. Verfasst von Luca Maddaloni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy. Hauptthemen laut MEDLINE: COVID-19, Pulmonary Surfactant-Associated Protein D, Biomarkers, Severity of Illness Index. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Given the various clinical manifestations that characterize Coronavirus Disease 2019 (COVID-19), the scientific community is constantly searching for biomarkers with prognostic value. Surfactant proteins A (SP-A) and D (SP-D) are collectins that play a crucial role in ensuring proper alveolar function and an alteration of their serum levels was reported in several pulmonary diseases characterized by Acute Respiratory Distress Syndrome (ARDS) and pulmonary fibrosis. Considering that such clinical manifestations can also occur during Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, we wondered if these collectins could act as prognostic markers. In this regard, serum levels of SP-A and SP-D were measured by enzyme immunoassay in patients with SARS-CoV-2 infection (n = 51) at admission (T0) and after seven days (T1) and compared with healthy donors (n = 11). SP-D increased in COVID-19 patients compared to healthy controls during the early phases of infection, while a significant reduction was observed at T1. Stratifying SARS-CoV-2 patients according to disease severity, increased serum SP-D levels were observed in severe compared to mild patients. In light of these results, SP-D, but not SP-A, seems to be an eligible marker of COVID-19 pneumonia, and the early detection of SP-D serum levels could be crucial for preventive clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
- Department of General and Specialistic Surgery, Sapienza University of Rome, 00185 Rome, Italy.
ORCID-Profile: Luca Maddaloni, Ginevra Bugani, Claudio Maria Mastroianni, Letizia Santinelli
Zitieren
APA
Maddaloni, L., Zullino, V., Bugani, G., Lazzaro, A., Brisciani, M., Mastroianni, C. M., Santinelli, L., & Ruberto, F. (2024). Could SP-A and SP-D Serum Levels Predict COVID-19 Severity?. International Journal of Molecular Sciences, 25(11), 5620. https://doi.org/10.3390/ijms25115620
Vancouver
Maddaloni L, Zullino V, Bugani G, Lazzaro A, Brisciani M, Mastroianni CM, et al. Could SP-A and SP-D Serum Levels Predict COVID-19 Severity?. International Journal of Molecular Sciences. 2024;25(11):5620. doi:10.3390/ijms25115620
BibTeX
@article{Maddaloni2024,
author = {Maddaloni, Luca and Zullino, Veronica and Bugani, Ginevra and Lazzaro, Alessandro and Brisciani, Matteo and Mastroianni, Claudio Maria and Santinelli, Letizia and Ruberto, Franco},
title = {Could SP-A and SP-D Serum Levels Predict COVID-19 Severity?},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {11},
pages = {5620},
doi = {10.3390/ijms25115620}
}
EUVIMED